Alacris Theranostics GmbH

Alacris Theranostics GmbH is a Berlin-based company with the mission to develop next-generation sequencing and other omics data for drug development and personalized oncology through its predictive modeling system, ModCellTM. This approach was initially developed at the Max Planck Institute for Molecular Genetics in Berlin and has been exclusively licensed to Alacris.